A detailed history of Parallel Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 59,678 shares of MRK stock, worth $5.87 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
59,678
Previous 60,783 1.82%
Holding current value
$5.87 Million
Previous $7.52 Million 9.93%
% of portfolio
0.16%
Previous 0.19%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $122,820 - $142,511
-1,105 Reduced 1.82%
59,678 $6.78 Million
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $278,302 - $298,894
2,248 Added 3.84%
60,783 $7.52 Million
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $554,423 - $646,027
4,896 Added 9.13%
58,535 $7.72 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $53,095 - $57,780
-530 Reduced 0.98%
53,639 $5.85 Million
Q3 2023

May 20, 2024

SELL
$102.95 - $114.33 $205,076 - $227,745
-1,992 Reduced 3.55%
54,169 $5.58 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $205,076 - $227,745
-1,992 Reduced 3.55%
54,169 $5.58 Million
Q2 2023

May 20, 2024

BUY
$108.61 - $118.38 $72,768 - $79,314
670 Added 1.21%
56,161 $6.48 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $72,768 - $79,314
670 Added 1.21%
56,161 $6.48 Million
Q1 2023

May 20, 2024

SELL
$102.94 - $114.86 $313,349 - $349,633
-3,044 Reduced 5.2%
55,491 $5.9 Million
Q1 2023

Apr 25, 2023

BUY
$102.94 - $114.86 $308,408 - $344,120
2,996 Added 5.71%
55,491 $5.9 Million
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $284,180 - $364,357
3,250 Added 6.6%
52,495 $5.82 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $781,226 - $877,620
9,242 Added 23.1%
49,245 $4.24 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $149,280 - $169,216
1,788 Added 4.68%
40,003 $3.65 Million
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $60,498 - $67,815
823 Added 2.2%
38,215 $3.15 Million
Q4 2021

Jan 20, 2022

SELL
$72.28 - $90.54 $284,277 - $356,093
-3,933 Reduced 9.52%
37,392 $2.87 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $220,129 - $242,086
3,071 Added 8.03%
41,325 $3.1 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $550,175 - $608,550
7,825 Added 25.72%
38,254 $2.98 Million
Q1 2021

Apr 23, 2021

SELL
$68.86 - $81.11 $104,804 - $123,449
-1,522 Reduced 4.76%
30,429 $2.35 Million
Q4 2020

Feb 02, 2021

SELL
$71.77 - $79.65 $335,811 - $372,682
-4,679 Reduced 12.77%
31,951 $2.61 Million
Q3 2020

Oct 27, 2020

SELL
$73.18 - $82.95 $46,103 - $52,258
-630 Reduced 1.69%
36,630 $3.04 Million
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $208,654 - $237,425
2,963 Added 8.64%
37,260 $2.88 Million
Q1 2020

Apr 27, 2020

BUY
$63.36 - $87.82 $51,575 - $71,485
814 Added 2.43%
34,297 $2.64 Million
Q4 2019

Jan 30, 2020

BUY
$77.58 - $87.54 $96,975 - $109,425
1,250 Added 3.88%
33,483 $3.05 Million
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $109,326 - $119,170
1,437 Added 4.67%
32,233 $2.71 Million
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $212,453 - $248,196
-3,042 Reduced 8.99%
30,796 $2.58 Million
Q1 2019

May 01, 2019

SELL
$69.58 - $79.36 $28,527 - $32,537
-410 Reduced 1.2%
33,838 $2.81 Million
Q4 2018

Feb 05, 2019

BUY
$65.24 - $75.71 $207,006 - $240,227
3,173 Added 10.21%
34,248 $2.62 Million
Q3 2018

Nov 01, 2018

BUY
$57.69 - $67.84 $72,862 - $85,681
1,263 Added 4.24%
31,075 $2.2 Million
Q2 2018

Jul 30, 2018

BUY
$50.83 - $59.72 $81,124 - $95,313
1,596 Added 5.66%
29,812 $1.81 Million
Q1 2018

May 08, 2018

SELL
$50.96 - $59.23 $36,436 - $42,349
-715 Reduced 2.47%
28,216 $1.54 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $3,355 - $4,006
65 Added 0.23%
28,931 $1.63 Million
Q3 2017

Nov 15, 2017

BUY
$58.67 - $63.13 $1.69 Million - $1.82 Million
28,866 New
28,866 $1.59 Million
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $1.78 Million - $1.91 Million
-30,286 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
30,286
30,286 $1.94 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.